Nutra Pharma Corp (NPHC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 114 | N/A | N/A | 14 | 23 |
| Receivables | 28 | 28 | 17 | 17 | 284 |
| Inventories | 37 | 37 | 35 | 42 | 59 |
| TOTAL | $223 | $93 | $115 | $225 | $573 |
| Non-Current Assets | |||||
| PPE Net | 8 | 9 | 11 | 12 | 13 |
| Other Non-Current Assets | 267 | 282 | 16 | 16 | 16 |
| TOTAL | $276 | $291 | $26 | $27 | $28 |
| Total Assets | $499 | $384 | $141 | $252 | $601 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,867 | 3,577 | 3,339 | 2,944 | 3,482 |
| Accounts payable and accrued liabilities | 1,858 | 869 | 804 | 1,533 | 1,415 |
| Accrued Expenses | 888 | 817 | 1,883 | 869 | 797 |
| Other current liabilities | 163 | 1,111 | 2 | 202 | 12 |
| TOTAL | $7,845 | $6,442 | $6,027 | $5,549 | $5,706 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 306 | 239 | 51 | 65 | 0 |
| TOTAL | $306 | $239 | $51 | $65 | $N/A |
| Total Liabilities | $8,151 | $6,681 | $6,078 | $5,614 | $5,706 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,214,350 | 6,855,197 | 6,855,197 | 4,020,246 | 3,637,448 |
| Common Shares | 5,038 | 4,128 | 4,047 | 4,014 | 3,241 |
| Retained earnings | -63,342 | -61,673 | -61,273 | -63,794 | -62,827 |
| TOTAL | $-7,652 | $-6,297 | $-5,937 | $-5,362 | $-5,105 |
| Total Liabilities And Equity | $498 | $384 | $141 | $252 | $601 |